November 2021
With vaccination programmes now in full swing throughout a multitude of nations, evidence supporting the need for booster shots to help defend against waning immunity and emerging variants has been mounting.
But while some countries are preparing to conduct a nationwide booster programme, elsewhere in the world governments have struggled to access enough vaccine supply to provide citizens with a primary dose.
This variance in vaccine rollouts has sparked international debate that wealthier nations are failing to address the pandemic on a global scale. To find out more, we examine the ethics of promoting third booster shots in the world’s wealthiest countries.
Also in the next issue, we get to grips with the realities of optimising real-world data in the fight against rare diseases, and explore the latest industry trends and innovations with GlobalData experts and analysts.
EDITORIAL
Editor | Eloise McLennan
Writers | Abi Millar, Darcy Jimenez, Kezia Parkins, Sy Chyi Yeoh
Magazine Designer | Maria Gimenez
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Filipe Costa, Martina Labaiova, Dimeji Akinkuolie, Will Ingham
Lead Designer | John Hammond
Publisher | Susanne Hauner
Digital Publishing Director | Duncan West
Advertising
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2021 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.
